Related Experiment Video
Updated: Feb 14, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α-XBP1 Activation
Zhifen Yang1, Jing Zhang1, Dadi Jiang2
1Department of Radiation Oncology, Stanford University, Stanford, California.
Abstract:
Activation of the unfolded protein response (UPR) signaling pathways is linked to multiple human diseases, including cancer. The inositol-requiring kinase 1α (IRE1α)-X-box binding protein 1 (XBP1) pathway is the most evolutionarily conserved of the three major signaling branches of the UPR. Here, we performed a genome-wide siRNA screen to obtain a systematic assessment of genes integrated in the IRE1α-XBP1 axis. We monitored the expression of an XBP1-luciferase chimeric protein in which luciferase was fused in-frame with the spliced (active) form of XBP1. Using cells expressing this reporter construct, we identified 162 genes for which siRNA inhibition resulted in alteration in XBP1 splicing. These genes express diverse types of proteins modulating a wide range of cellular processes. Pathway analysis identified a set of genes implicated in the pathogenesis of breast cancer. Several genes, including BCL10, GCLM, and IGF1R, correlated with worse relapse-free survival (RFS) in an analysis of patients with triple-negative breast cancer (TNBC). However, in this cohort of 1,908 patients, only high GCLM expression correlated with worse RFS in both TNBC and non-TNBC patients. Altogether, our study revealed unidentified roles of novel pathways regulating the UPR, and these findings may serve as a paradigm for exploring novel therapeutic opportunities based on modulating the UPR.Implications: Genome-wide RNAi screen identifies novel genes/pathways that modulate IRE1α-XBP1 signaling in human tumor cells and leads to the development of improved therapeutic approaches targeting the UPR.Visual Overview: http://mcr.aacrjournals.org/content/molcanres/16/5/745/F1.large.jpg Mol Cancer Res; 16(5); 745-53. ©2018 AACR.
Insights
A genome-wide screen identified 162 genes regulating the unfolded protein response (UPR) via the IRE1α-XBP1 pathway. Some genes, like GCLM, are linked to worse survival in breast cancer patients, suggesting new therapeutic targets for UPR modulation.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Signaling Pathways
Background:
- The unfolded protein response (UPR) is implicated in human diseases, notably cancer.
- The inositol-requiring kinase 1α (IRE1α)-X-box binding protein 1 (XBP1) pathway is a critical UPR signaling branch.
- Understanding genes that modulate the IRE1α-XBP1 axis is crucial for cancer research.
Purpose of the Study:
- To systematically identify genes involved in the IRE1α-XBP1 signaling pathway using a genome-wide screen.
- To explore the role of these identified genes in cancer pathogenesis, particularly breast cancer.
- To uncover novel therapeutic strategies targeting the UPR in cancer.
Main Methods:
- Conducted a genome-wide siRNA screen in cells expressing an XBP1-luciferase reporter.
- Monitored alterations in XBP1 splicing upon gene inhibition.
- Performed pathway analysis and correlated gene expression with patient survival data.
Main Results:
- Identified 162 genes that modulate XBP1 splicing when inhibited by siRNA.
- These genes regulate diverse cellular processes and include those implicated in breast cancer.
- High GCLM expression correlated with worse relapse-free survival in both triple-negative and non-triple-negative breast cancer patients.
Conclusions:
- The study reveals novel genes and pathways regulating the IRE1α-XBP1 signaling pathway.
- Findings provide a foundation for developing new therapeutic approaches targeting the UPR in cancer.
- Modulating the UPR presents a promising paradigm for cancer treatment.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genomics
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Experimental RNAi
Cell Diversity
Multicellular...

